Expression of P53 ,Livin and PARP in epithelial ovarian cancer and its impact on chemotherapy resistance and clinical prognosis
10.3969/j.issn.1673-4130.2017.04.008
- VernacularTitle:上皮性卵巢癌P53、Livin和PARP表达检测及其对卵巢癌化疗耐药、临床预后的影响研究
- Author:
Minli JIA
;
Xiaotong SONG
- Keywords:
epithelial ovarian cancer;
chemotherapy resistance;
clinical prognosis
- From:
International Journal of Laboratory Medicine
2017;38(4):452-454
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression of P53 ,Livin and PARP in epithelial ovarian cancer and its correlation with the chemotherapy resistance and clinical prognosis.Methods Seventy-four specimens of epithelial ovarian cancer confirmed by opera-tion and pathology in the gynecology department of our hospital from January 2009 to June 2011 were selected ,followed up and di-vided into chemotherapy sensitivity group and chemotherapy resistance group according to the recurrence condition.The difference of drug resistance genes ,survival rate and influencing factors of survival time were compared between the two groups.Results The positive rates of P53 ,Livin and PARP in the chemotherapy sensitivity group were 47.1% ,56.9% and 52.9% respectively ,which in the chemotherapy resistance group were 73.9% ,95.7% and 95.7% respectively ,the sensitivity rate of each item in the chemother-apy sensitivity group was lower than that in the chemotherapy resistance group (P<0.05).The median survival time in the survival rate in the chemotherapy sensitivity group was 52.0 months ,its 3-year and 5-year survival rates were 68.63% and 41.18% respec-tively ,the medium survival time in the chemotherapy resistance group was 31.5 months ,its 3-year and 5-year survival rates were 47.83% and 26.10% respectively ,the survival rate of various stages in the chemotherapy sensitivity group was higher than that in the chemotherapyresistance group ,the difference was statistically significant (P< 0.05).The age ,pathological differentiation de-gree ,clinical staging and chemotherapy sensitivity degree were introduced into the Cox regression model ,the clinical staging and chemotherapy sensitivity degree had significant influence on the survival time (P<0.05).Conclusion The expression of P53 ,Livin and PARP is correlated with the chemotherapy resistance in the patients with epithelial ovarian cancer ,therefore ,which can be used to predict the chemotherapeutic effect.For the patients with high expression of drug resistance genes ,the personalized coping scheme may be given for improving the patient's prognosis.
